FDA Inspection

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)April 30, 2009

FDA Inspection 584548 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - April 30, 2009

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), with an inspection on April 30, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
Inspection Date: April 30, 2009
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 8a8fa07d-e58b-4844-8e97-d62539570ab8